PHARMACOLOGICAL CHARACTERIZATION OF A HISTONE DEACETYLASE INHIBITOR AND TUMOR CELL-GROWTH INHIBITION PROPERTIES OF NEW BENZOFURANONE COMPOUNDS

被引：0
|
作者：
Blanquart, Christophe [1 ]
Francois, Manon [1 ]
Charrier, Cedric [2 ]
Bertrand, Philippe [2 ]
Gregoire, Marc [1 ]
机构：
[1] INSERM, U892, F-75654 Paris 13, France
[2] CNRS, Umr 6514, F-75700 Paris, France
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
Cancer; HDAC inhibitors; BRET;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S924 / S924
页数：1
相关论文
共 50 条
  • [41] TUMOR-INHIBITION BY FERRICENIUM COMPLEXES - SYSTEMIC EFFECT INVIVO AND CELL-GROWTH INHIBITION INVITRO
    KOPFMAIER, P
    ZEITSCHRIFT FUR NATURFORSCHUNG C-A JOURNAL OF BIOSCIENCES, 1985, 40 (11-12): : 843 - 846
  • [42] Histone deacetylase 3 overexpression in human cholangiocarcinoma and promotion of cell growth via apoptosis inhibition
    Yin, Yuyao
    Zhang, Mingming
    Dorfman, Robert Gregory
    Li, Yang
    Zhao, Zhenguo
    Pan, Yida
    Zhou, Qian
    Huang, Shan
    Zhao, Shimin
    Yao, Yuling
    Zou, Xiaoping
    CELL DEATH & DISEASE, 2017, 8 : e2856 - e2856
  • [43] Histone deacetylase 3 overexpression in human cholangiocarcinoma and promotion of cell growth via apoptosis inhibition
    Yuyao Yin
    Mingming Zhang
    Robert Gregory Dorfman
    Yang Li
    Zhenguo Zhao
    Yida Pan
    Qian Zhou
    Shan Huang
    Shimin Zhao
    Yuling Yao
    Xiaoping Zou
    Cell Death & Disease, 2017, 8 : e2856 - e2856
  • [44] INHIBITION OF CELL-GROWTH BY BAFILOMYCIN A(1), A SELECTIVE INHIBITOR OF VACUOLAR H+-ATPASE
    OHKUMA, S
    SHIMIZU, S
    NOTO, M
    SAI, Y
    KINOSHITA, K
    TAMURA, HO
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 1993, 29A (11) : 862 - 866
  • [45] Low Dosed Interferon Alpha Augments the Anti-Tumor Potential of Histone Deacetylase Inhibition on Prostate Cancer Cell Growth and Invasion
    Hudak, Lukasz
    Tezeeh, Patrick
    Wedel, Steffen
    Makarevic, Jasmina
    Juengel, Eva
    Tsaur, Igor
    Bartsch, Georg
    Wiesner, Christoph
    Haferkamp, Axel
    Blaheta, Roman A.
    PROSTATE, 2012, 72 (16): : 1719 - 1735
  • [46] Histone deacetylase-10 liberates spermidine to support polyamine homeostasis and tumor cell growth
    Stewart, Tracy Murray
    Foley, Jackson R.
    Holbert, Cassandra E.
    Klinke, Glynis
    Poschet, Gernot
    Steimbach, Raphael R.
    Miller, Aubry K.
    Casero Jr, Robert A.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2022, 298 (10)
  • [47] Vorinostat: a new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma
    Duvic, Madeleine
    Vu, Jenny
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (07) : 1111 - 1120
  • [48] The histone deacetylase inhibitor romidepsin synergizes with lenalidomide and enhances tumor cell death in T-cell lymphoma cell lines
    Cosenza, Maria
    Civallero, Monica
    Fiorcari, Stefania
    Pozzi, Samantha
    Marcheselli, Luigi
    Bari, Alessia
    Ferri, Paola
    Sacchi, Stefano
    CANCER BIOLOGY & THERAPY, 2016, 17 (10) : 1094 - 1106
  • [49] A novel histone deacetylase inhibitor, Scriptaid, induces growth inhibition, cell cycle arrest and apoptosis in human endometrial cancer and ovarian cancer cells
    Takai, N
    Ueda, T
    Nishida, M
    Nasu, K
    Narahara, H
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2006, 17 (02) : 323 - 329
  • [50] The effects of histone deacetylase (HDAC) inhibitor, CRA-026440, on angiongenesis, signal transduction and tumor growth.
    Cao, Z. Alexander
    Bass, Kathryn E.
    Balasubramanian, Sriram
    Liu, Liang
    Dai, Yuchin
    Sendzik, Martin
    Molina, Rafael A.
    Orr, Christine J.
    Davis, Jack R.
    Leung, Ling
    Buggy, Joseph J.
    Dalrymple, Stacie A.
    CANCER RESEARCH, 2006, 66 (08)
12345